Drug intelligence / Profile preview

Lyber+

Development stage
Unknown
Lead developer
Anglo-French Drugs & Industries
Modality
Small Molecules
Administration
Oral
01

Overview

Lyber+ is a multi-ingredient nutraceutical supplement developed and marketed by Anglo-French Drugs & Industries (AFDIL). It is formulated to support vitality, energy levels, and overall health, particularly in the context of male reproductive wellness and general metabolic support. The product contains a synergistic blend of antioxidants and micronutrients, including Coenzyme Q10 (Ubidecarenone), L-Carnitine L-Tartrate, Lycopene, Astaxanthin, Zinc, and Selenium. These components work to enhance mitochondrial function, improve cellular energy production, and protect tissues from oxidative damage. Lyber+ is typically used as a dietary supplement to manage fatigue, support energy metabolism, and provide nutritional support for various physiological functions.

Brand names
Lyber+
02

Targets

ND1 (Mitochondrial electron transport chain complex I)CPT1A (Carnitine palmitoyltransferase 1A)

Beyond the preview

Go deeper on Lyber+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyber+.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call